First published · Last updated
P1.11.30 The Efficacy of Immunotherapyfor Patients With Advanced Lung Cancer and Oncogenic Driver Alterations
This is a journal article reporting on the efficacy of immunotherapy in patients with advanced lung cancer who have oncogenic driver alterations. The supplied source data included only the title, publisher, content type, and publication date with no results or study details.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 2/10
- Geographic reach
- 1/10
- Global importance
- 2/10
- Impact magnitude
- 2/10
- Positivity
- 5/10
- Urgency
- 1/10
Why it matters
The article topic is directly relevant to treatment outcomes for a defined subgroup of advanced lung cancer patients.

